Your browser doesn't support javascript.
loading
Trial summary and protocol for a phase II randomised placebo-controlled double-blinded trial of Interleukin 1 blockade in Acute Severe Colitis: the IASO trial.
Thomas, Martin Geoffrey; Bayliss, Carrie; Bond, Simon; Dowling, Francis; Galea, James; Jairath, Vipul; Lamb, Christopher; Probert, Christopher; Timperley-Preece, Elizabeth; Watson, Alastair; Whitehead, Lynne; Williams, John G; Parkes, Miles; Kaser, Arthur; Raine, Tim.
Afiliação
  • Thomas MG; Cambridge Clinical Trials Unit, Cambridge, UK.
  • Bayliss C; Cambridge Clinical Trials Unit, Cambridge, UK.
  • Bond S; Cambridge Clinical Trials Unit, Cambridge, UK.
  • Dowling F; MRC Biostatistics Unit, Cambridge, UK.
  • Galea J; Cambridge Clinical Trials Unit, Cambridge, UK.
  • Jairath V; University of Manchester, Manchester, UK.
  • Lamb C; Division of Gastroenterology, Department of Medicine, Western University, London, Ontario, Canada.
  • Probert C; Division of Epidemiology and Biostatistics, Western University, London, Ontario, Canada.
  • Timperley-Preece E; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
  • Watson A; Department of Gastroenterology, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK.
  • Whitehead L; Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
  • Williams JG; Coventry, UK.
  • Parkes M; Department of Gastroenterology, University of East Anglia, Norwich, UK.
  • Kaser A; Clinical Trials Pharmacy Department, Addenbrooke's Hospital, Cambridge, UK.
  • Raine T; Swansea University Medical School, Swansea, UK.
BMJ Open ; 9(2): e023765, 2019 02 15.
Article em En | MEDLINE | ID: mdl-30772849

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Colite Ulcerativa / Corticosteroides / Antirreumáticos / Proteína Antagonista do Receptor de Interleucina 1 Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Colite Ulcerativa / Corticosteroides / Antirreumáticos / Proteína Antagonista do Receptor de Interleucina 1 Idioma: En Ano de publicação: 2019 Tipo de documento: Article